Results 161 to 170 of about 288,402 (222)

Liver organoids: From 3D printing to biomedical applications

BMEMat, EarlyView.
A comprehensive review on liver organoids culture techniques from 3D printing to organ‐on‐chip, as well as focusing on challenges and perspectives for advancement liver organoids in various future applications. Abstract The liver is an immune organ, especially an immune tolerance organ.
Ying Shi, Xin Han, Zheng Zhang, Jiangtao Xu, Guozhen Liu   +4 more
wiley   +1 more source

Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials. [PDF]

BMC Gastroenterol
Lei X, Huo W, Xu T, Xu J, Liu M, Liu C, Gu Z.   +6 more
europepmc   +1 more source

Engineering antibodies with cancer‐associated binding sites

BMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian, Yumeng Pan, Yingchun Zhang, Fangling Wang, Zejun Wang   +4 more
wiley   +1 more source

Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial. [PDF]

Front Immunol
Wei J, Zhang P, Hu Q, Cheng X, Shen C, Chen Z, Zhuang W, Yin Y, Zhang B, Gou H, Yang K, Bi F, Liu M.   +12 more
europepmc   +1 more source

Efficacy of Combined PD-1 Inhibitor and Bevacizumab in Unresectable Liver Metastasis of MSI-H Colorectal Cancer: A Case Report. [PDF]

Am J Case Rep
Wang Q, Zhong J, Wang Y, Bao J, Li S, Yang L.   +5 more
europepmc   +1 more source

Preventive Photobiomodulation for Chemotherapy-Induced Oral Mucositis: A Systematic Review of Randomized Clinical Trials. [PDF]

Biomedicines
Parra-Rojas S, Velázquez-Cayón RT, Ciortan-Pop ME, Martins MD, Cassol Spanemberg J.   +4 more
europepmc   +1 more source

Complete Remission with Nivolumab Monotherapy of Advanced Gastric Neuroendocrine Carcinoma. [PDF]

Intern Med
Tajima K, Shimodate Y, Mouri H, Nagahisa Y, Nishina S, Mizuno M.   +5 more
europepmc   +1 more source

Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory setting. [PDF]

Pharmacol Res Perspect
AbuAloush Z, Awad W, Mashni O, Shkakhwa F, Al-Faris A, Al-Omari M, Nabulsi S, Nazer L.   +7 more
europepmc   +1 more source

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities

Cancer Communications, EarlyView.
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan, Jinling Song, Yuqing Ren, Yuyuan Zhang, Yuhao Ba, Peng Luo, Quan Cheng, Hui Xu, Siyuan Weng, Anning Zuo, Shutong Liu, Xinwei Han, Jinhai Deng, Zaoqu Liu   +13 more
wiley   +1 more source

Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer - real-world single-centre data. [PDF]

Acta Oncol
Patachi B, Jensen KH, Gothelf A, Bernsdorf M, Friborg J, Kristensen CA.   +5 more
europepmc   +1 more source